The Effect of Enhanced External Counterpulsation on Platelet Aggregation in Patients with Coronary Heart Disease
ConclusionEECP therapy is favorable for lowering platelet aggregation in patients with CHD, especially the AA-induced platelet aggregation ratio.
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research
More News: Aspirin | Cardiology | Cardiovascular | Clopidogrel | Coronary Heart Disease | Heart | Heart Disease | Plavix